5326 Results

People

  1. De Angelis
    De Angelis
  2. Drilon
    Drilon
  3. Motzer
    Motzer
  4. Mellinghoff
    Mellinghoff
  5. Holland
    Holland
  6. Rosenblum
    Rosenblum
  7. Dunkel
    Dunkel
  8. Shuman
    Shuman
  9. Saltz
    Saltz
  10. Karajannis
    Karajannis

Groups

  1. Department of Medicine (2263)
  2. Solid Tumor Oncology Division (1803)
  3. GSK Faculty (822)
  4. Survivorship Research (785)
  5. Population Sciences Research Program (749)
  6. Epidemiology and Biostatistics (518)
  7. Surgery (489)
  8. Department of Pathology and Laboratory Medicine (454)
  9. Gastrointestinal Oncology Service (445)
  10. Sloan Kettering Institute Faculty (414)
  1. "Oxford University Press"
Formats
  1. Journal Article (2563)
  2. Meeting Abstract (2095)
  3. Book Section (345)
  4. Review (108)
  5. Editorial (92)
  6. Guidelines (35)
  7. Book Whole (28)
  8. Correspondence (27)
  9. Conference Paper (20)
  10. Research Letter (12)
  11. Miscellaneous (1)
Groups
  1. Department of Medicine (2263)
  2. Solid Tumor Oncology Division (1803)
  3. GSK Faculty (822)
  4. Survivorship Research (785)
  5. Population Sciences Research Program (749)
  6. Epidemiology and Biostatistics (518)

More Groups

People
  1. Lisa De Angelis (121)
  2. Alexander Drilon (111)
  3. Robert Motzer (110)
  4. Ingo Mellinghoff (93)
  5. Jimmie Holland (91)
  6. Marc Rosenblum (89)

More People

Years
  1. 2025 (59)
  2. 2024 (347)
  3. 2023 (359)
  4. 2022 (360)
  5. 2021 (360)
  6. 2020 (356)

More Years

Publications
  1. Annals of Oncology (1662)
  2. Neuro-Oncology (843)
  3. JNCI: Journal of the National Cancer Institute (481)
  4. The Oncologist (287)
  5. Nucleic Acids Research (209)
  6. Clinical Infectious Diseases (137)

More Publications

Publishers
  1. Oxford University Press (5326)

Results (5326)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Selecting patients with triple negative breast cancer for platinum-based therapy: We still haven't found what we're looking for
    Journal Article

    Robson, M.
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Surrogate end points in lymphoma
    Journal Article

    Batlevi, C. L.; Younes, A.
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Pathology principles and practices for analysis of animal models
    Journal Article

    Knoblaugh, S. E.; Hohl, T. M.; La Perle, K. M. D.
    ILAR Journal (2018)

    Fulltext@MSK | Save
  • Prospective evaluation of cerebrospinal fluid circulating tumor cells (CSF CTC) in patients with HER2 positive cancers and leptomeningeal metastases receiving treatment with intrathecal trastuzumab
    Meeting Abstract

    Pentsova, E.; Malani, R.; Fleisher, M.; Lin, X.; Omuro, A.; Groves, M.; Lin, N.; Melisko, M.; Lassman, A.; Jeyapalan, S.; more...
    Neuro-Oncology (2018)

    Fulltext@MSK | Save
  • Modeling the safety of topical agents for skin toxicity associated with tumor treating fields therapy in glioblastoma
    Meeting Abstract

    Lacouture, M.; Hershkovich, H.; Giladi, M.; Blat, R.; Bomzon, Z.; Kirson, E.; Weinberg, U.; Palti, Y.
    Neuro-Oncology (2018)

    Fulltext@MSK | Save
  • G-quadruplex DNA drives genomic instability and represents a targetable molecular abnormality in ATRX-deficient malignant glioma
    Meeting Abstract

    Wang, Y.; Yang, J.; Wu, W.; Shah, R.; Danussi, C.; Riggins, G.; Kannan, K.; Sulman, E.; Chan, T.; Huse, J.
    Neuro-Oncology (2018)

    Fulltext@MSK | Save
  • Precise investigation of cancer stem cells in a mouse glioblastoma model
    Meeting Abstract

    Xie, X.; Laks, D.; Sun, D.; Poran, A.; Laughney, A.; Belenguer, G.; Massague, J.; Zhou, X.; Farinas, I.; Elemento, O.; more...
    Neuro-Oncology (2018)

    Fulltext@MSK | Save
  • Characteristics of patients with neurocutaneous melanosis: The MSK experience from 2003-2018
    Meeting Abstract

    Ennin, E.; De Braganca, K.; Haque, S.; Marghoob, A.; Khakoo, Y.
    Neuro-Oncology (2018)

    Fulltext@MSK | Save
  • A Phase 1, multicenter, randomized, open-label, perioperative study of AG-120 (ivosidenib) and AG-881 in patients with recurrent, nonenhancing, IDH1-mutant, low-grade glioma
    Meeting Abstract

    Mellinghoff, I.; Maher, E.; Wen, P.; Cloughesy, T.; Peters, K.; Choi, C.; Ellingson, B.; Lin, A.; Li, Y.; Soher, B.; more...
    Neuro-Oncology (2018)

    Fulltext@MSK | Save
  • Genomic attributes of tumor evolution and treatment response in diffuse glioma
    Meeting Abstract

    Lin, A. L.; Jonsson, P.; Ogilvie, S.; Chavan, S.; Nolan, C.; Gavrilovic, I.; Kaley, T.; Grommes, C.; Pentsova, E.; Diamond, E.; more...
    Neuro-Oncology (2018)

    Fulltext@MSK | Save